|

rondecabtagene autoleucel Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LYL314

Pipeline

Phase 3: 1

Top Sponsors

  • Lyell Immunopharma, Inc.1

Indications

  • Diffuse Large B Cell Lymphoma Relapsed1
  • Diffuse Large B Cell Lymphoma Refractory1
  • Non-Hodgkin Lymphoma Refractory/ Relapsed1
  • Lymphoma, B-Cell1
  • Large B-cell Lymphoma1

Gilbert, Arizona1 trial

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Banner MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.